• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Impact of Older Donor Age on Recipient and Graft Survival After LDLT: The US Experience.老年供者年龄对 LDLT 后受者和移植物存活率的影响:美国经验。
Transplantation. 2023 Jan 1;107(1):162-171. doi: 10.1097/TP.0000000000004289. Epub 2022 Aug 31.
2
Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes.美国活体供肝移植:频率、结果、中心容量的演变,以及与结果相关的因素。
Liver Transpl. 2021 Jul;27(7):1019-1031. doi: 10.1002/lt.26029. Epub 2021 Jun 24.
3
Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.美国不断增加高 MELD 评分活体供肝肝移植的实践并获得可接受的结果。
Liver Transpl. 2024 Jan 1;30(1):72-82. doi: 10.1097/LVT.0000000000000228. Epub 2023 Jul 26.
4
Defining long-term outcomes with living donor liver transplantation in North America.界定北美活体供肝移植的长期预后。
Ann Surg. 2015 Sep;262(3):465-75; discussion 473-5. doi: 10.1097/SLA.0000000000001383.
5
A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.肝移植供体与受体重比小于 0.8 不能排除成人-成人右半活体肝移植。
Liver Transpl. 2009 Dec;15(12):1776-82. doi: 10.1002/lt.21955.
6
Impact of Advanced Renal Dysfunction on Posttransplant Outcomes After Living Donor Liver Transplantation in the United States.美国活体肝移植后晚期肾功能障碍对移植后结局的影响。
Transplantation. 2021 Dec 1;105(12):2564-2570. doi: 10.1097/TP.0000000000003728.
7
Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.与接受 deceased donor 移植的匹配队列相比,成人活体供肝移植后的移植物和患者生存率。 (注:这里“deceased donor”直译为“已故供体”,结合医学语境,通常指脑死亡后器官捐献的供体,国内一般称为“尸体供肝”,但按照任务要求未添加注释说明)
Liver Transpl. 2004 Oct;10(10):1263-8. doi: 10.1002/lt.20254.
8
Superior survival using living donors and donor-recipient matching using a novel living donor risk index.使用活体供体可提高生存率,并通过一种新型活体供体风险指数进行供体-受体匹配。
Hepatology. 2014 Nov;60(5):1717-26. doi: 10.1002/hep.27307. Epub 2014 Oct 2.
9
Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.成人对成人活体肝移植队列研究中的复发性原发性硬化性胆管炎:活体供肝与尸体供肝受者的危险因素比较
Liver Transpl. 2016 Sep;22(9):1214-22. doi: 10.1002/lt.24496. Epub 2016 Aug 2.
10
Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.发展、管理和解决活体和已故供体肝移植后的胆系并发症:来自成人对成人活体供肝移植队列研究联盟的报告。
Liver Transpl. 2013 Mar;19(3):259-67. doi: 10.1002/lt.23595.

引用本文的文献

1
Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation.依维莫司可降低肝移植后肝细胞癌复发风险。
Cancers (Basel). 2024 Mar 22;16(7):1243. doi: 10.3390/cancers16071243.
2
cGAS-STING pathway in ischemia-reperfusion injury: a potential target to improve transplantation outcomes.cGAS-STING 通路在缺血再灌注损伤中的作用:改善移植结局的潜在靶点。
Front Immunol. 2023 Sep 21;14:1231057. doi: 10.3389/fimmu.2023.1231057. eCollection 2023.

老年供者年龄对 LDLT 后受者和移植物存活率的影响:美国经验。

Impact of Older Donor Age on Recipient and Graft Survival After LDLT: The US Experience.

机构信息

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.

Division of Transplant Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA.

出版信息

Transplantation. 2023 Jan 1;107(1):162-171. doi: 10.1097/TP.0000000000004289. Epub 2022 Aug 31.

DOI:10.1097/TP.0000000000004289
PMID:36042545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9771867/
Abstract

BACKGROUND

The impact of selecting older donors for living donor liver transplantation (LDLT) in the United States is incompletely studied, particularly in light of the recent expansion of LDLT nationally.

METHODS

Adult LDLTs from January 01, 2005 to December 31, 2019 were identified using the United Network for Organ Sharing database. Multivariable Cox models evaluated living donor (LD) age as a predictor of LDLT recipient and graft survival. The impact of increasing donor age on recipient outcomes was compared between LD and deceased donor recipients. Donor postoperative outcomes were evaluated.

RESULTS

There were 3539 LDLTs at 65 transplant centers during the study period. Despite the recent expansion of LDLT, the proportion of LDs aged ≥50 y was stable. There were no clinically significant differences in recipient or donor characteristics by LD age group. LD age ≥50 y was associated with an adjusted hazard ratio of 1.49 ( P = 0.012) for recipient survival and 1.61 ( P < 0.001) for graft survival (vs LDs aged 18-29 y). The negative impact of increasing donor age on graft survival was more profound after LDLT than deceased donor liver transplantation (interaction P = 0.019). There was a possible increased rate of early donor biliary complications for donors >55 y (7.1% versus 3.1% for age <40 y; P = 0.156).

CONCLUSIONS

Increasing LD age is associated with decreased recipient and graft survival, although older donors still largely yield acceptable outcomes. Donor outcomes were not clearly impacted by increasing age, though this warrants further study.

摘要

背景

在美国,选择老年供体进行活体肝移植(LDLT)的影响尚未得到充分研究,尤其是考虑到 LDLT 在全国范围内的最近扩张。

方法

使用美国器官共享网络数据库确定 2005 年 1 月 1 日至 2019 年 12 月 31 日期间的成人 LDLT。多变量 Cox 模型评估活体供体(LD)年龄作为 LDLT 受者和移植物存活的预测因子。比较 LD 和已故供体受者之间增加供体年龄对受者结局的影响。评估供体术后结局。

结果

在研究期间,有 3539 例 LDLT 在 65 个移植中心进行。尽管 LDLT 最近有所扩张,但≥50 岁 LD 的比例保持稳定。LD 年龄组之间的受者或供者特征没有临床显著差异。LD 年龄≥50 岁与调整后的受者存活率风险比 1.49(P=0.012)和移植物存活率风险比 1.61(P<0.001)相关(与 18-29 岁 LD 相比)。在 LDLT 后,增加供体年龄对移植物存活率的负面影响比已故供体肝移植更严重(交互 P=0.019)。年龄>55 岁的供体早期胆并发症发生率可能增加(7.1%与年龄<40 岁时的 3.1%相比;P=0.156)。

结论

LD 年龄的增加与受者和移植物存活率降低相关,但老年供体仍主要产生可接受的结果。供体结局并未明显受到年龄增加的影响,但这需要进一步研究。